Cargando…
High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition
Cerebral cavernous malformations (CCMs) are vascular malformations that can be the result of the deficiency of one of the CCM genes. Their only present treatment is surgical removal, which is not always possible, and an alternative pharmacological strategy to eliminate them is actively sought. We ha...
Autores principales: | Sartages, Miriam, Floridia, Ebel, García-Colomer, Mar, Iglesias, Cristina, Macía, Manuel, Peñas, Patricia, Couraud, Pierre-Olivier, Romero, Ignacio A., Weksler, Babette, Pombo, Celia M., Zalvide, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766026/ https://www.ncbi.nlm.nih.gov/pubmed/33348877 http://dx.doi.org/10.3390/biomedicines8120624 |
Ejemplares similares
-
The cerebral cavernous malformation 3 gene is necessary for senescence induction
por: Guerrero, Ana, et al.
Publicado: (2015) -
Tyrosine Kinases in Cancer
por: Blau, Olga, et al.
Publicado: (2015) -
Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
por: Stern, David F
Publicado: (2000) -
Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014) -
Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn
por: Li, Chuanzhou, et al.
Publicado: (2018)